We are live on ! Find out more
Jeff Yass

Jeff Yass Susquehanna International Group

AUM $1.28T Turnover 24.66%
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+35.7%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$1.28T
AUM Growth
+$391B
Cap. Flow
+$19.1B
Cap. Flow %
1.49%
Top 10 Hldgs %
26.66%
Holding
15,023
New
1,956
Increased
5,793
Reduced
5,445
Closed
1,748
Avg Time Held Equity + Options
3.8 years
Top 10 Avg Time Held Equity + Options
5.1 years
Top 20 Avg Time Held Equity + Options
5.8 years
Avg Time Held Equity only
2.2 years
Top 10 Avg Time Held Equity only
1.8 years
Top 20 Avg Time Held Equity only
3.4 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 93.8%
2 Technology 2.93%
3 Communication Services 0.62%
4 Consumer Discretionary 0.61%
5 Industrials 0.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
TOVX icon
13176
Theriva Biologics
TOVX
$6.61M
$6.02K ﹤0.01%
+24,064
New +$7.13K
2026 Q2
0 quarters
OPENL icon
13177
Opendoor Technologies Inc Series A Warrants
OPENL
$450K
$5.94K ﹤0.01%
21,022
– –
2025 Q4
2 quarters
CYCU icon
13178
Cycurion Inc
CYCU
$8.68M
$5.92K ﹤0.01%
+1,279
New +$9.33K
2026 Q2
0 quarters
TPET icon
13179
Trio Petroleum
TPET
$9.1M
$5.85K ﹤0.01%
+2,096
New +$8.22K
2026 Q2
0 quarters
BKKT.WS icon
13180
DELISTED
Bakkt Inc Warrants
BKKT.WS
$5.82K ﹤0.01%
90,176
+10,414
+13% +$883
2021 Q4
18 quarters
OSRH
13181
DELISTED
OSR Health
OSRH
$5.78K ﹤0.01%
+18,282
New +$9.16K
2026 Q2
0 quarters
GOSS icon
13182
PUT
Gossamer Bio
GOSS
$67.1M
$5.76K ﹤0.01%
450
-2,514
-85% -$56.1K
2025 Q3
3 quarters
ONCHW icon
13183
1RT Acquisition Corp Warrant
ONCHW
$981K
$5.64K ﹤0.01%
+11,060
New +$5.24K
2026 Q2
0 quarters
AIDX icon
13184
20/20 Biolabs Inc
AIDX
$2.73M
$5.5K ﹤0.01%
+10,014
New +$12.6K
2026 Q2
0 quarters
CRGOW icon
13185
Freightos Ltd Warrant
CRGOW
$2.11M
$5.41K ﹤0.01%
108,722
+50,561
+87% +$5.03K
2025 Q4
2 quarters
CUBWW icon
13186
Lionheart Holdings Warrant
CUBWW
$5.25K ﹤0.01%
14,196
-28,087
-66% -$6.59K
2025 Q4
2 quarters
SLAI
13187
DELISTED
SOLAI Ltd ADS
SLAI
$5.08K ﹤0.01%
1,580
+61
+4% +$298
2024 Q4
6 quarters
HVIIR
13188
DELISTED
Hennessy Capital Investment Corp VII Rights
HVIIR
$5K ﹤0.01%
12,843
-12,715
-50% -$4.53K
2026 Q1
1 quarter
NTWOW icon
13189
Newbury Street II Acquisition Corp Warrant
NTWOW
$5.69M
$4.93K ﹤0.01%
19,601
+653
+3% +$126
2025 Q2
4 quarters
ILLRW
13190
DELISTED
TRILLER GROUP INC WTS
ILLRW
$4.79K ﹤0.01%
+74,776
New +$3.36K
2026 Q2
0 quarters
VIVK icon
13191
Vivakor
VIVK
$153K
$4.74K ﹤0.01%
+48
New +$17.5K
2026 Q2
0 quarters
AUROW
13192
DELISTED
Aurora Innovation Warrant
AUROW
$4.66K ﹤0.01%
+14,573
New +$4.96K
2026 Q2
0 quarters
HRTX icon
13193
PUT
Heron Therapeutics
HRTX
$59.1M
$4.64K ﹤0.01%
10,800
-2,800
-21% -$2.24K
2026 Q1
1 quarter
PWCM icon
13194
PowerCompute Inc
PWCM
$892K
$4.63K ﹤0.01%
+1,241
New +$7.25K
2026 Q2
0 quarters
VVOS icon
13195
Vivos Therapeutics
VVOS
$1.97M
$4.58K ﹤0.01%
+10,075
New +$7.9K
2026 Q2
0 quarters
NPACW icon
13196
New Providence Acquisition Corp III Warrants
NPACW
$1.12M
$4.43K ﹤0.01%
+15,808
New +$4.44K
2026 Q2
0 quarters
USBC icon
13197
USBC Inc
USBC
$140M
$4.34K ﹤0.01%
+13,873
New +$5.28K
2026 Q2
0 quarters
JSPR icon
13198
PUT
Jasper Therapeutics
JSPR
$15.2M
$4.33K ﹤0.01%
+343
New +$7.7K
2026 Q2
0 quarters
GFAI icon
13199
Guardforce AI
GFAI
$4.64M
$4.3K ﹤0.01%
10,815
-56,820
-84% -$27.4K
2025 Q2
4 quarters
RCON icon
13200
Recon Technology
RCON
$18.3M
$4.26K ﹤0.01%
53
-134
-72% -$19.3K
2025 Q3
3 quarters

Similar funds

Jeff Yass's Q2 2026 Portfolio in Review

As of Q2 2026, Jeff Yass held 15,023 positions worth $1.28T, up 44% from $893B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jeff Yass's Q2 2026 filing shows 1,956 new, 5,793 increased, 5,445 reduced and 1,748 closed positions. Its largest new stake was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M. The largest sale was Invesco QQQ Trust, an estimated $1.78B.

By sector, the portfolio is most concentrated in Miscellaneous at 94% of assets, down from 94% a quarter earlier, followed by Technology and Communication Services.

  • Jeff Yass's largest Q2 2026 buy was Vanguard Total International Bond ETF: 5,720,864 shares worth $277M.
  • Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $2.87B increase.
  • Jeff Yass's biggest Q2 2026 reduction was Invesco QQQ Trust, cutting an estimated $1.78B.
  • Jeff Yass fully exited iShares MSCI Emerging Markets ex China ETF in Q2 2026, selling an estimated $142M.
  • Jeff Yass's ten largest holdings make up 27% of its $1.28T portfolio in Q2 2026.
  • Jeff Yass opened 1,956 new positions and closed 1,748 in Q2 2026.
  • Jeff Yass's portfolio value rose 44% quarter-over-quarter to $1.28T.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.